ALSO NOTED: Bayer sues Watson over Yasmin; Zimmer weeds out doc … - FiercePharma
|
ALSO NOTED: Bayer sues Watson over Yasmin; Zimmer weeds out doc …
FiercePharma, DC - 21 hours ago … share price drop by 22 percent over the past six months as investors worry that patients aren't switching to the ADHD treatment Vyvanse, its lead drug. … |
Find Out More:
Books:
- ADHD: Attention-Deficit Hyperactivity Disorder in Children, Adolescents, and Adults
- Concerta Side Effects
- Journeys Through ADDulthood: Discover a New Sense of Identity and Meaning with Attention Deficit Disorder
- The Attention Deficit Answer Book: The Best Medications and Parenting Strategies for Your Child
- Beyond Ritalin: Facts About Medication and Other Strategies for Helping Children, Adolescents, and Adults with Attention Deficit Disorders
April 22nd, 2008
Vyvanse
Leave a Reply